Market Overview:
The global HIV diagnosis and treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of HIV/AIDS, growing awareness about HIV/AIDS, and technological advancements in the field of diagnostics and treatment. The global HIV diagnosis and treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into antibody tests, viral identification assays, cd4 testing, viral load testing Early infant diagnostics). On the basis of application;the market is segmented into diagnostic laboratories hospitals blood banks home care settings).
Product Definition:
A diagnosis of HIV infection is made when a person has certain specific symptoms and tests positive for the virus. HIV is a virus that attacks the body's immune system, specifically the CD4 cells, which help fight infections. When left untreated, HIV can damage the immune system and affect different parts of the body. AIDS (acquired immunodeficiency syndrome) is a later stage of HIV infection that can occur when damage to the immune system is extensive.
Treatment for HIV involves taking anti-HIV drugs called antiretrovirals (ARVs). ARVs work by blocking or interfering with replication of the virus in order to keep it from making copies of itself in your body. Taking ARVs as prescribed can help people living with HIV stay healthy and delay or prevent development of AIDS.
Antibody Tests:
Antibody tests are used for diagnosis of HIV infection. These tests detect presence of antibodies produced in response to HIV virus. Presence or absence of these antibodies is taken into consideration while diagnosing HIV infection and designing an appropriate treatment regimen. The test works on the basis that if a person has been exposed to the virus, then certain antibodies will be detected in his/her blood sample; if not, no antibody will be detected (negative test result).
Viral Identification Assays:
Viral Identification Assays are used for the identification of viruses in biological samples. Viral Identification assays help in determining the type of virus infection is present on a particular date and helps to track viral infections. These tests also aid in monitoring the effectiveness of antiviral drugs during treatment as these tests provide an early warning regarding drug resistance, thus helping doctors to alter or discontinue medication as required.
Application Insights:
Based on application, the global HIV diagnosis and treatment market is segmented into diagnostic laboratories, hospitals, blood banks and other settings (hospitals and clinics), as well as home care settings. The hospital segment dominated the overall market in terms of revenue in 2017 due to a large number of patients suffering from AIDS at present. Moreover, an increase in funding for research initiatives by governments across the globe has led to an increase in R&D activities pertaining to HIV which is expected to boost product demand over the forecast period.
The home care setting segment is anticipated to witness lucrative growth over the forecast period owing to increasing awareness about early diagnosis & treatment among individuals at risk of acquiring HIV through sexual contact or needle sharing habits with multiple partners or intravenous drug use (IDU). This has led many people living with AIDS (PLWHA) throughout the world today opt for early testing & diagnostics thereby fueling demand for these products globally.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, advanced healthcare infrastructure and high awareness levels among people about HIV are some of the factors responsible for its large share. Moreover, government initiatives to control this disease is also one of the major reasons behind its large revenue share. For instance, as per CDC’s National Center for Health Statistics (NCHS), in 2015 around 11% population in U.S had been diagnosed with HIV at any point during their lifetime and another 2% were not sure if they were infected or not but was aware that they could be infected with it (1).
Growth Factors:
- Increasing incidence of HIV/AIDS: The global incidence of HIV is increasing at an alarming rate. According to the World Health Organization (WHO), around 36 million people were living with HIV in 2015, and 2 million people died from AIDS-related causes. This number is expected to increase in the coming years due to various factors such as population growth and aging, increased sexual activity among young people, and lack of awareness about prevention measures. The high prevalence of HIV/AIDS worldwide provides a large potential market for diagnostic and treatment products.
- Rising government funding for research on new treatments: The global market for HIV diagnosis and treatment is expected to grow significantly in the next few years due to rising government funding for research on new treatments. In particular, major pharmaceutical companies are investing heavily in developing novel drugs that can cure or prevent AIDS-related infections. This will help drive down the cost of diagnosis and treatment over time, making them more affordable for patients around the world.
Scope Of The Report
Report Attributes
Report Details
Report Title
HIV Diagnosis and Treatment Market Research Report
By Type
Antibody Tests, Viral Identification Assays, Cd4 Testing, Viral Load Testing, Early Infant Diagnostics
By Application
Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings
By Companies
Siemens Healthcare, Abbott, Roche, Bio-Rad, QIAGEN, Danaher, BD, Merck, BioMerieux, MedMira, Hologic
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
185
Number of Tables & Figures
130
Customization Available
Yes, the report can be customized as per your need.
Global HIV Diagnosis and Treatment Market Report Segments:
The global HIV Diagnosis and Treatment market is segmented on the basis of:
Types
Antibody Tests, Viral Identification Assays, Cd4 Testing, Viral Load Testing, Early Infant Diagnostics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Siemens Healthcare
- Abbott
- Roche
- Bio-Rad
- QIAGEN
- Danaher
- BD
- Merck
- BioMerieux
- MedMira
- Hologic
Highlights of The HIV Diagnosis and Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibody Tests
- Viral Identification Assays
- Cd4 Testing
- Viral Load Testing
- Early Infant Diagnostics
- By Application:
- Diagnostic Laboratories
- Hospitals
- Blood Banks
- Home Care Settings
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the HIV Diagnosis and Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
HIV diagnosis is the process of identifying a person as having HIV. Treatment for HIV is the combination of antiretroviral medications and other supportive care to help people live longer, healthier lives.
Some of the major companies in the hiv diagnosis and treatment market are Siemens Healthcare, Abbott, Roche, Bio-Rad, QIAGEN, Danaher, BD, Merck, BioMerieux, MedMira, Hologic.
The hiv diagnosis and treatment market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 HIV Diagnosis and Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 HIV Diagnosis and Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 HIV Diagnosis and Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the HIV Diagnosis and Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global HIV Diagnosis and Treatment Market Size & Forecast, 2020-2028
4.5.1 HIV Diagnosis and Treatment Market Size and Y-o-Y Growth
4.5.2 HIV Diagnosis and Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Antibody Tests
5.2.2 Viral Identification Assays
5.2.3 Cd4 Testing
5.2.4 Viral Load Testing
5.2.5 Early Infant Diagnostics
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Diagnostic Laboratories
6.2.2 Hospitals
6.2.3 Blood Banks
6.2.4 Home Care Settings
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global HIV Diagnosis and Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 HIV Diagnosis and Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Antibody Tests
9.6.2 Viral Identification Assays
9.6.3 Cd4 Testing
9.6.4 Viral Load Testing
9.6.5 Early Infant Diagnostics
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Diagnostic Laboratories
9.10.2 Hospitals
9.10.3 Blood Banks
9.10.4 Home Care Settings
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Antibody Tests
10.6.2 Viral Identification Assays
10.6.3 Cd4 Testing
10.6.4 Viral Load Testing
10.6.5 Early Infant Diagnostics
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Diagnostic Laboratories
10.10.2 Hospitals
10.10.3 Blood Banks
10.10.4 Home Care Settings
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Antibody Tests
11.6.2 Viral Identification Assays
11.6.3 Cd4 Testing
11.6.4 Viral Load Testing
11.6.5 Early Infant Diagnostics
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Diagnostic Laboratories
11.10.2 Hospitals
11.10.3 Blood Banks
11.10.4 Home Care Settings
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Antibody Tests
12.6.2 Viral Identification Assays
12.6.3 Cd4 Testing
12.6.4 Viral Load Testing
12.6.5 Early Infant Diagnostics
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Diagnostic Laboratories
12.10.2 Hospitals
12.10.3 Blood Banks
12.10.4 Home Care Settings
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Antibody Tests
13.6.2 Viral Identification Assays
13.6.3 Cd4 Testing
13.6.4 Viral Load Testing
13.6.5 Early Infant Diagnostics
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Diagnostic Laboratories
13.10.2 Hospitals
13.10.3 Blood Banks
13.10.4 Home Care Settings
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 HIV Diagnosis and Treatment Market: Competitive Dashboard
14.2 Global HIV Diagnosis and Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Siemens Healthcare
14.3.2 Abbott
14.3.3 Roche
14.3.4 Bio-Rad
14.3.5 QIAGEN
14.3.6 Danaher
14.3.7 BD
14.3.8 Merck
14.3.9 BioMerieux
14.3.10 MedMira
14.3.11 Hologic
